Tim Smith is an Advisor at 64x Bio. Tim is currently SVP, Head of Corporate Development at PMV Pharma.

‍

Prior to joining PMV, Tim was the Chief Business Officer of Verseau Therapeutics. He has held senior business development leadership roles at IDEAYA Biosciences, Cleave Biosciences, and Celgene Corporation. Tim spent his early career in equity research covering the biotechnology sector at RBC Capital Markets, Lazard Capital Markets, and Citi Research.

‍

Tim holds a BS in Biology from the University of Texas at Arlington, an MBA in Finance from Fordham University and an MA in Biotechnology from Columbia University. Tim has led numerous M&A, in-licensing and strategic equity investment transactions.